Srs Capital Advisors, Inc. Fibrogen Inc Transaction History
Srs Capital Advisors, Inc.
- $1.07 Billion
- Q3 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Fibrogen Inc stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 3,681 shares of FGEN stock, worth $1,288. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,681
Previous 3,681
-0.0%
Holding current value
$1,288
Previous $3,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding FGEN
# of Institutions
82Shares Held
47.1MCall Options Held
387KPut Options Held
672K-
Primecap Management CO Pasadena, CA9.91MShares$3.47 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.8MShares$2.38 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.88MShares$2.06 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.91MShares$1.37 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.41MShares$843,3770.0% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $32.8M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...